FDA finds further flaws in Theranos, this time around its Zika tests

 This past week, the U.S. Food and Drug Administration mandated testing for the Zika virus at all U.S. blood centers. That juices demand for Zika-testing technology, but one company that isn’t welcome to provide it yet is Theranos. The beleaguered blood analysis startup has run afoul of the F.D.A., yet again, the Wall Street Journal’s John Carreyrou reports. Specifically… Read More